Position in MYGN
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$316,084
-$137,404 QoQ
Shares Held
70,241
-4.7% QoQ
Ownership
0.074%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in MYGN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Creative Planning holds $213,176,142 across 30 Diagnostics & Research names. MYGN ranks #25 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
129,348 | $63,578,422 | |
| 2 | DHR |
Danaher Corp /De/
|
188,295 | $35,700,731 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
37,170 | $20,885,450 | |
| 4 | A |
Agilent Technologies, Inc.
|
121,999 | $13,905,446 | |
| 5 | IQV |
Iqvia Holdings Inc.
|
51,674 | $8,812,483 | |
| 6 | ILMN |
Illumina, Inc.
|
69,584 | $8,576,923 | |
| 7 | MTD |
Mettler Toledo International Inc/
|
6,367 | $8,030,060 | |
| 8 | MEDP |
Medpace Holdings, Inc.
|
16,032 | $7,698,406 |
All Filings in MYGN
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $316,084 | 70,241 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $453,488 | 73,738 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $561,893 | 77,717 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $180,130 | 33,923 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $213,935 | 24,119 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $945 | 69 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $272,502 | 9,949 | Shares | Defined | 2024-10-11 | |
| 2024-06-30 | $221,533 | 9,057 | Shares | Defined | 2024-08-15 | |
| No filing history on record for this holder in this stock. | ||||||